Carbamazepine vs Oxcarbazepine

How they're similar

Carbamazepine and oxcarbazepine share the same basic mechanism and a lot of the same character.

• Both are sodium channel blockers. They calm overactive electrical firing in nerve cells, which is how they work in seizures and, less directly, in bipolar disorder.
• Both started as anticonvulsants. Carbamazepine has FDA approval for bipolar I disorder. Oxcarbazepine is used off-label for bipolar disorder, meaning it's used for the condition even though the label doesn't list it, and evidence supports the use though it's weaker.
• Both can cause Stevens-Johnson syndrome and toxic epidermal necrolysis, severe skin reactions. Both are affected by the HLA-B1502 genetic variant, and HLA-B1502 testing is recommended before starting either drug in patients of Han Chinese, Thai, Filipino, Malaysian, South Asian, or Indonesian ancestry.
• Both can cause low sodium through SIADH, though the rate is higher with oxcarbazepine.
• Both can cause dizziness, sedation, double vision, ataxia (unsteadiness), and rash.
• Both have interactions with birth control, though the strength of the interaction is different.
• People with a rash from carbamazepine have about a one in four chance of reacting to oxcarbazepine too, since the drugs are chemically similar.

The overlap is real. If someone has had a serious reaction to one, that's usually a reason to avoid the other.

How they differ

The key difference is a metabolite. Carbamazepine gets broken down in the liver into a compound called the 10,11-epoxide, and that metabolite drives a lot of the toxicity and enzyme induction that make carbamazepine so troublesome. Oxcarbazepine was designed to skip that step. It's broken down into a different metabolite that's more active in the useful sense and less involved in the problematic interactions. The table below covers the core differences.

The interaction difference is the reason many prescribers picked oxcarbazepine when it came out. Carbamazepine strongly induces CYP3A4 and several other enzymes, which is why it drops the level of birth control pills, several antipsychotics, several antidepressants, and a long list of other drugs. Oxcarbazepine is a much weaker inducer. At lower doses the induction is barely noticeable. At higher doses it does start to induce CYP3A4, and it still weakens hormonal birth control, so a backup method or a non-hormonal option is usually recommended for anyone on oxcarbazepine who needs contraception. But the overall interaction burden is much smaller than carbamazepine's.

Carbamazepine also auto-induces its own metabolism, meaning the enzymes that break it down get more efficient during the first month of treatment. That's why the dose has to keep going up in the first few weeks to hold the level steady. Oxcarbazepine doesn't do this, so its dosing is more predictable.

Blood level monitoring is a real practical difference. Carbamazepine needs regular level checks because the therapeutic window is narrow and because the level drifts during auto-induction. Oxcarbazepine doesn't have a well-established therapeutic level, and routine monitoring isn't done in most patients. It's still checked in specific situations, like when compliance is in question or when high doses aren't working, but it's not part of the usual care.

Aplastic anemia and agranulocytosis, both rare blood problems, are recognized risks with carbamazepine and are part of why CBC monitoring is standard. Oxcarbazepine doesn't carry the same signal in the data.

The SJS/TEN risk isn't gone with oxcarbazepine. It's lower than with carbamazepine, but it's real, and HLA-B*1502 testing is still recommended in the same ancestries before starting oxcarbazepine. Anyone who's had a rash on carbamazepine has about a 25 to 30 percent chance of having a rash on oxcarbazepine, so it's not a safe substitute in that setting.

Hyponatremia is the one thing that got worse. Carbamazepine causes low sodium in something like 10 to 15 percent of patients. Oxcarbazepine causes it in 25 to 30 percent, and the rate goes up with dose and with age. Low sodium can be silent or it can cause headaches, nausea, fatigue, confusion, unsteadiness, and in severe cases, seizures. It's the reason a baseline and follow-up sodium check are standard on oxcarbazepine, especially in older adults.

The evidence base in bipolar disorder is the reason carbamazepine still gets used despite everything. Carbamazepine has controlled trials showing benefit in acute mania and mixed states, and it has FDA approval for bipolar I. Oxcarbazepine has fewer and smaller trials, most of them not clearly positive, and it's used off-label. That doesn't mean it doesn't work. It means the evidence is weaker, and prescribers use it more often as an add-on or when carbamazepine isn't tolerated.

Side effect tendencies

The everyday side effects overlap a lot. Both cause dizziness, sedation, unsteadiness, headache, and double vision, especially early or after a dose increase. Both can cause nausea, and taking the dose with food often helps.

Where they part ways is in the specific risks. Oxcarbazepine causes low sodium more often, and that's what a prescriber is looking for on the follow-up labs. Older adults are more at risk. Symptoms can be subtle. Carbamazepine causes rash more often, and any new rash on carbamazepine gets attention right away because of the SJS/TEN risk. Carbamazepine is also more likely to cause blood count problems, both mild (transient neutropenia) and rare severe ones (aplastic anemia, agranulocytosis), which is why CBCs are drawn regularly.

Neither drug is a gentle medication, and both are worth a real conversation with the prescriber before starting.

What tips the choice

For seizures, oxcarbazepine is often preferred over carbamazepine because of the cleaner interaction profile. For bipolar disorder, carbamazepine has the evidence and the approval, and oxcarbazepine is more often used as an option when carbamazepine isn't a good fit or hasn't been tolerated.

A clinician might choose oxcarbazepine when the patient is on a long list of other medications, when the auto-induction pattern of carbamazepine is a hassle, when hyponatremia isn't a major concern (younger adult, no other drugs that lower sodium), or when the prescriber wants to skip the level monitoring. It's also picked sometimes for tolerability, since it tends to cause less GI upset and less blood-count trouble.

A clinician might choose carbamazepine when the evidence base matters (bipolar with a specific pattern of mixed states, rapid cycling), when hyponatremia is a real risk (older adult, other drugs that lower sodium), or when insurance drives the choice, since generic carbamazepine is inexpensive.

Some concrete scenarios. A 25-year-old with bipolar II and no other medications, where a prescriber wants to try an anticonvulsant mood stabilizer, could reasonably start on either, and the choice often comes down to insurance and prescriber preference. A 70-year-old with bipolar disorder on several other medications is a poor fit for oxcarbazepine because of hyponatremia risk, and lithium or a different agent might be a better fit. A patient of Han Chinese ancestry needs HLA-B*1502 testing before either drug. A patient with rapid cycling that hasn't responded to lithium or valproate has stronger evidence to try carbamazepine than oxcarbazepine.

Common questions

If oxcarbazepine is a safer version, why isn't it used more in bipolar? Because the evidence in bipolar disorder isn't as strong. The redesign fixed interactions and some safety issues, but the studies in bipolar disorder haven't consistently shown the same benefit that carbamazepine has. That's the honest reason. Prescribers still use oxcarbazepine off-label, and it can work, but the evidence base is thinner and it's rarely first choice for bipolar.

Do I still need HLA testing for oxcarbazepine? Yes, if you're of Han Chinese, Thai, Filipino, Malaysian, South Asian, or Indonesian ancestry. The SJS/TEN risk with oxcarbazepine is lower than with carbamazepine but not zero, and the HLA-B*1502 variant is still associated with it. Testing is a one-time blood test done before starting.

Why does oxcarbazepine cause more low sodium? The mechanism isn't fully understood. It appears to be a dose-related effect on antidiuretic hormone, causing the kidneys to hold onto water and dilute the sodium in the blood. Older adults, patients on diuretics, and patients on higher oxcarbazepine doses are the highest risk. It's the reason a sodium check is standard on the follow-up labs.

Can I switch from carbamazepine to oxcarbazepine directly? It's done, but the doses aren't the same. Oxcarbazepine doses are usually about 1.5 times higher than the carbamazepine dose being replaced. The switch is done gradually, and the prescriber watches for return of symptoms as well as for new side effects, especially low sodium. If the reason for the switch was a rash on carbamazepine, oxcarbazepine may not be a safe alternative.

Does either drug affect birth control? Yes, both do, though carbamazepine is a stronger effect. Carbamazepine strongly reduces the effectiveness of hormonal birth control (pill, patch, ring, and to some extent the implant). Oxcarbazepine also reduces it, especially at higher doses. Non-hormonal options like the copper IUD, or a backup barrier method, are usually recommended. This is worth a specific conversation with both the prescriber and the person managing contraception.

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes.

1. U.S. Food and Drug Administration. Carbamazepine prescribing information.
2. U.S. Food and Drug Administration. Oxcarbazepine prescribing information.
3. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder.
4. MedlinePlus, U.S. National Library of Medicine.
5. National Institute of Mental Health. Bipolar disorder.